Masimo (MASI) Change in Accured Expenses (2009 - 2026)
Masimo's (MASI) quarterly Change in Accured Expenses came in at -$29.9 million in Q2 2026, down 4171.43% year-on-year from $734386.0 in Q2 2025, and down 425.0% quarter-over-quarter from $9.2 million in Q1 2026.
Masimo (MASI) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Masimo's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$29.9 million for Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 4171.43% year-over-year to -$29.9 million in Q2 2026; TTM through Apr 2026 was -$17.0 million, a 189.47% decrease from a year earlier, with the FY2026 full-year figure at $12.2 million, down 45.05% from the prior year.
- Change in Accured Expenses retreated to -$29.9 million in Q2 2026 per MASI's latest filing, from $9.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $30.6 million in Q4 2022 and bottomed at -$29.9 million in Q2 2026.
- The 5-year median for Change in Accured Expenses is -$400000.0 (2022), against an average of -$438388.9.
- Across the five-year window, Change in Accured Expenses surged 8400.0% in 2023 and slumped 4171.43% in 2026, its largest moves.
- Year by year, Change in Accured Expenses stood at $30.6 million in 2022, then slumped by 74.84% to $7.7 million in 2023, then soared by 194.81% to $22.7 million in 2024, then slumped by 122.03% to -$5.0 million in 2025, then tumbled by 498.0% to -$29.9 million in 2026.
- Per Business Quant, the three latest MASI Change in Accured Expenses figures stand at -$29.9 million (Q2 2026), $9.2 million (Q1 2026), and -$5.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -29.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -29.90 Mn |
| Apr 4, 2026 | -29.90 Mn |
| Jan 3, 2026 | 9.20 Mn |
| Jan 3, 2026 | 9.20 Mn |
| Sep 27, 2025 | -5.00 Mn |
| Sep 27, 2025 | -5.00 Mn |
| Jun 28, 2025 | 8.70 Mn |
| Jun 28, 2025 | 8.70 Mn |
| Mar 29, 2025 | -700,000.00 |
| Mar 29, 2025 | -700,000.00 |
| Dec 28, 2024 | 22.70 Mn |
| Dec 28, 2024 | 22.70 Mn |
| Sep 28, 2024 | 1.30 Mn |
| Sep 28, 2024 | 1.30 Mn |
| Jun 29, 2024 | -4.30 Mn |
| Jun 29, 2024 | -4.30 Mn |
| Mar 30, 2024 | 2.50 Mn |
| Mar 30, 2024 | 2.50 Mn |
| Dec 30, 2023 | 7.70 Mn |
| Dec 30, 2023 | 7.70 Mn |